Rajiv Sharma, MD
Gastroenterology · Bay City, MINPI 1770797359
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.1%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by AbbVie at 34.6% of the total. Reporting peaked in 2019 at $2,761 and has fallen 79.3% since, to $570 in 2025.
Across 141 payments — averaging $50.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Takeda Pharmaceuticals U.S.A., Inc.$397
- Madrigal Pharmaceuticals$354
- Gilead$299
- Janssen Scientific Affairs, LLC$281
- plus $1K from 22 others
Across 4 payments — averaging $12,198 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$49K
What the payments were for
- Consulting fees$1,79325%
- Speaking & faculty fees$2,00028%
- Food & beverage$3,16844%
- Education$2243%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $2,486 |
| Johnson & Johnson | 28 | $2,218 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $397 |
| Madrigal Pharmaceuticals | 7 | $354 |
| Gilead | 9 | $299 |
| Janssen Scientific Affairs, LLC | 1 | $281 |
| Boston Scientific | 6 | $172 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Evoke Pharma, Inc. | 1 | $117 |
| Amgen | 1 | $114 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $91 |
| Olympus America Inc. | 2 | $80 |
| Nestle Healthcare Nutrition Inc. | 4 | $69 |
| Intercept Pharmaceuticals, Inc. | 3 | $44 |
| Ambu Inc. | 1 | $43 |
| Boehringer Ingelheim | 2 | $39 |
| Echosens North America, Inc. | 2 | $33 |
| Merck | 2 | $30 |
| Shire North American Group Inc | 2 | $29 |
| Braintree Laboratories, Inc. | 2 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Pfizer | 1 | $19 |
| Cook Medical LLC | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Medtronic | 1 | $17 |
| Vivus LLC | 1 | $17 |
| Novo Nordisk | 1 | $14 |
| UCB, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,185 in reported general payments places this provider in the 75th percentile of 497 gastroenterology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 31 | $638 |
| Omeprazole | 26 | $558 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Bay City
- Kimberly BrownDetroit$733K
- Dilip MoonkaDetroit$611K
- Philip SchoenfeldAnn Arbor$539K
- Michelle Muza-MoonsAnn Arbor$481K
- Partha NandiTroy$377K
- Bradford WhitmerSaint Clair Shores$206K
- Mohammed BarawiSt Clair Shores$193K
- Stuart GordonDetroit$178K
- Mohamad AlsibaeRoyal Oak$127K
- Allison SchulmanAnn Arbor$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.